NYMC Faculty Publications
COVID-19, Cardiovascular Diseases and Cardiac Troponins
Author Type(s)
Faculty
DOI
10.2217/fca-2021-0054
Journal Title
Future Cardiology
First Page
135
Last Page
142
Document Type
Article
Publication Date
2-1-2022
Department
Medicine
Abstract
There has been strong evidence of myocardial injury in COVID-19 patients with significantly elevated serum cardiac troponin (cTn). While the exact mechanism of injury is unclear, possible suggested pathological mechanisms of injury are discussed. These include increased susceptibility of the myocardium and endothelium to viral invasion, underlying hyperinflammatory state and subsequent cytokine storm, a hypercoagulable and prothrombotic state, and indirect myocardial injury due to hypoxemia. As a result of these pathological mechanisms in COVID-19 patients, cTn may be elevated largely due to myocarditis, microangiopathy or myocardial infarction. The utility of cTn as a biomarker for measuring myocardial injury in these patients and assessing its ability as a prognostic factor for clinical outcome is also discussed.
Recommended Citation
Kim, C. W., & Aronow, W. S. (2022). COVID-19, Cardiovascular Diseases and Cardiac Troponins. Future Cardiology, 18 (2), 135-142. https://doi.org/10.2217/fca-2021-0054